Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Nov;99(11):4488-96.
doi: 10.1002/jps.22180.

Formulation and immunogenicity studies of type III secretion system needle antigens as vaccine candidates

Affiliations

Formulation and immunogenicity studies of type III secretion system needle antigens as vaccine candidates

Brooke S Barrett et al. J Pharm Sci. 2010 Nov.

Abstract

Bacterial infections caused by Shigella flexneri, Salmonella typhimurium, and Burkholderia pseudomallei are currently difficult to prevent due to the lack of a licensed vaccine. Here we present formulation and immunogenicity studies for the three type III secretion system (TTSS) needle proteins MxiH(Δ5), PrgI(Δ5), and BsaL(Δ5) (each truncated by five residues at its C terminus) as potential candidates for vaccine development. These antigens are found to be thermally stabilized by the presence of carbohydrates and polyols. Additionally, all adsorb readily to aluminum hydroxide apparently through a combination of hydrogen bonds and/or Van der Waals forces. The interaction of these proteins with the aluminum-based adjuvant changes with time resulting in varying degrees of irreversible binding. Peptide maps of desorbed protein, however, suggest that chemical changes are not responsible for this irreversible association. The ability of MxiH(Δ5) and PrgI(Δ5) to elicit strong humoral immune responses was tested in a murine model. When administered intramuscularly as monomers, the needle components exhibited dose dependent immunogenic behavior. The polymerized version of MxiH was exceptionally immunogenic even at low doses. The responses of both monomeric and polymerized forms were boosted by adsorption to an aluminum salt adjuvant.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Circular dichroism thermal melting curves for each MxiH Δ5 (formula image), PrgI Δ5 (formula image) and BsaL Δ5 (formula image) at 0.2 mg/mL in isotonic 10 mM Histidine buffer at pH 6.0.
Figure 2
Figure 2
Changes in Tm (°C) as measured by circular dichroism spectroscopy for MxiH Δ5 (formula image) and PrgI Δ5 (formula image).
Figure 3
Figure 3
Circular dichroism thermal melting curves for (A) MxiH Δ5 and (B) PrgI Δ5 at 222 nm in the presence (formula image) and absence (-) of 10% Sucrose and 5% Dextrose.
Figure 4
Figure 4
Adsorption isotherms for MxiH Δ5 (A), PrgI Δ5 (B) and BsaL Δ5 (C) with 0.5 mg/mL aluminum in isotonic 10 mM histidine buffer at pH 6. Solid lines represent 100% adsorption.
Figure 5
Figure 5
Absorbance values observed at 450 nm when each sample was plated and analyzed by a standard ELISA protocol.
Figure 6
Figure 6
Anti MxiH (A and B) and PrgI (C) IgG serum responses following intramuscular injections on study days 1, 14, 28 of Buffer Control (formula image), Alhydrogel Control (formula image), M1/M-His/P1 (formula image), M10/M-Al/P10 (formula image), M50/N-His/P50 (formula image). N-Al/P-Soln (formula image).

Similar articles

Cited by

References

    1. Shigella. 2009 [cited 2009 February 19]; Available from: http://www.who.int/vaccine_research/diseases/shigella/en/
    1. World Health Organiation Drug-Resistant Salmonella. 2005 [cited 2009 February 19]; Available from: http://www.who.int/mediacentre/factsheets/fs139/en/print.html.
    1. Salmonella Saintpaul Outbreak. 2008 [cited 2009 February 19]; Available from: http://www.fda.gov/oc/opacom/hottopics/tomatoes.html.
    1. Peanut Product Recalls: Salmonella Typhimurium. 2008 [cited 2009 February 19]; Available from: http://www.fda.gov/oc/opacom/hottopics/Salmonellatyph.html.
    1. National Center for Zoonotic V-B, and Enteric Diseases (ZVED). Melioidosis. 2008 March 27 2008 [cited 2009 February 20]; Available from: http://www.cdc.gov/nczved/dfbmd/disease_listing/melioidosis_gi.html.

Publication types

MeSH terms